← Open Payments lookup

ANGEL MATHEW: Open Payments

NPI 1487284261 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$508 in 19 payments from 11 companies in 2025. Trend: 2023 $372 · 2024 $695 · 2025 $508

Food & beverage: $508
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$171
ABBVIE INC.4$74
Legend Biotech USA Inc.3$61
Daiichi Sankyo Inc.2$47
Novartis Pharmaceuticals Corporation2$40
Agios Pharmaceuticals, Inc.1$23
Genentech USA, Inc.1$21
GENZYME CORPORATION1$20
Incyte Corporation1$19
SOBI, INC1$17

Products named: CALQUENCE, CARVYKTI, Vanflyta, Fabhalta, EPKINLY, VENCLEXTA, PYRUKYND, Polivy.

Industry payments across TX — which companies pay providers there.